American Medical Association. Featured report: generic drugs (A-02) full text. http://www.ama-assn.org/ama/pub/category/15279.html. Accessed September 4, 2007.
Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology. 2007;68(20):1701-1709.
Begley CE, Famulari M, Annegers JF, et al. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia. 2000;41(3):342-351.
Berkovic SF VF. Letters: Generics- equal or not? Australian Prescriber. 2003;26(6):124-125.
Biton V. Weight change and antiepileptic drugs: health issues and criteria for appropriate selection of an antiepileptic agent. Neurologist. 2006;12(3):163-167.
Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology. 1999;52(7):1330-1337.
Biton V, Sackellares JC, Vuong A, Hammer AE, Barrett PS, Messenheimer JA. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology. 2005;65(11):1737-1743.
British Epilepsy Association. Policy position statement: consistency of supply. http://www.epilepsy.org.uk/about/positionstatements/consistencyofsupply.html Accessed September 5, 2007.
Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res. 1999;37(1):81-87.
Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68(6):402-408.
Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet. 1995;345(8948):476-479.
Brunton L. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11 ed. New York: McGraw-Hill; 2006.
Centers for Disease Control and Prevention. Epilepsy. http://www.cdc.gov/Epilepsy. Accessed September 5, 2007.
Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia. 2007;48(3):484-489.
Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia. 2005;46 Suppl 9:117-124.
Epilepsy Foundation. Understanding epilepsy: epilepsy and seizure statistics. http://www.epilepsyfoundation.org/about/statistics.cfm. Accessed September 5, 2007.
Epilepsy Foundation of the Chesapeake Region. Epilepsy: more common than you think. http://www.epilepsy-foundation.org/efcrFactsFigures.htm. Accessed September 5, 2007.
Ettinger AB, Kustra RP, Hammer AE. Effect of lamotrigine on depressive symptoms in adult patients with epilepsy. Epilepsy Behav. 2007;10(1):148-154.
French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2004;62(8):1252-1260.
Holmes LB, Wyszynski DF, Lieberman E. The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol. 2004;61(5):673-678.
Jeha LE, Morris HH. Optimizing outcomes in pregnant women with epilepsy. Cleve Clin J Med. 2005;72(10):938-940, 942-935.
Jensen TS. Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain. 2002;6 Suppl A:61-68.
KEPPRA® (levetiracetam) tablets and oral solution prescribing information. Smyrna, Ga. UBC, Inc.; March 2007. http://www.keppra.com/pc/global/Keppra_Full_PI.pdf. Accessed September 7, 2007.
LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review. Jama. 2004;291(5):605-614.
Leppik IE. Choosing an antiepileptic. Selecting drugs for older patients with epilepsy. Geriatrics. 2005;60(11):42-47.
Leppik IE, Bergey GK, Ramsay RE, et al. Advances in antiepileptic drug treatments. A rational basis for selecting drugs for older patients with epilepsy. Geriatrics. 2004;59(12):14-18, 22-14.
Morita S, Miwa H, Kondo T. Effect of zonisamide on essential tremor: a pilot crossover study in comparison with arotinolol. Parkinsonism Relat Disord. 2005;11(2):101-103.
Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry. 2006;77(2):193-198.
Motte J, Trevathan E, Arvidsson JF, Barrera MN, Mullens EL, Manasco P. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group. N Engl J Med. 1997;337(25):1807-1812.
Nadkarni S, LaJoie J, Devinsky O. Current treatments of epilepsy. Neurology. 2005;64(12 Suppl 3):S2-11.
National Institute for Health and Clinical Excellence. NICE Clinical guideline 20. http://guidance.nice.org.uk/CG20. Accessed September 7, 2007.
National Institute of Neurological Disorders and Stroke. Seizures and epilepsy: hope through research. http://www.ninds.nih.gov/disorders/epilepsy/detail_epilepsy.htm. Accessed September 5, 2007.
O'Brien MD, Gilmour-White SK. Management of epilepsy in women. Postgrad Med J. 2005;81(955):278-285.
Ochoa JG, Riche W. Antiepileptic Drugs: An Overview. eMedicine. http://www.emedicine.com/neuro/topic692.htm. Accessed September 7, 2007
Ondo WG, Jankovic J, Connor GS, et al. Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology. 2006;66(5):672-677.
Perucca E. An introduction to antiepileptic drugs. Epilepsia. 2005;46 Suppl 4:31-37.
Perucca E, Albani F, Capovilla G, Bernardina BD, Michelucci R, Zaccara G. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs. Epilepsia. 2006;47 Suppl 5:16-20.
Petrenaite V, Sabers A, Hansen-Schwartz J. Individual changes in lamotrigine plasma concentrations during pregnancy. Epilepsy Res. 2005;65(3):185-188.
Privitera MD, Brodie MJ, Mattson RH, Chadwick DW, Neto W, Wang S. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand. 2003;107(3):165-175.
Privitera MD, Cavitt J, Ficker DM, Szaflarski JP, Welty TE, Kaplan MJ. Clinician's Guide to Antiepileptic Drug Use. Philadelphia, Pa: Lippincott Williams & Wilkins; 2006.
Sachdeo RC, Glauser TA, Ritter F, Reife R, Lim P, Pledger G. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group. Neurology. 1999;52(9):1882-1887.
SIGN: Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults: Guideline #70. http://www.sign.ac.uk/guidelines/fulltext/70/index.html. Accessed September 7, 2007.
Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia. 1999;40(5):601-607.
Tatum WO, IV., Galvez R, Benbadis S, Carrazana E. New antiepileptic drugs: into the new millennium. Arch Fam Med. 2000;9(10):1135-1141.
Tonstad S, Tykarski A, Weissgarten J, et al. Efficacy and safety of topiramate in the treatment of obese subjects with essential hypertension. Am J Cardiol. 2005;96(2):243-251.
TOPAMAX® (topiramate) tablets and capsules prescribing information. Titusville, NJ. Ortho-McNeil Neurologics, Inc.; March 2007. https://www.ortho-mcneilneurologics.com/ortho-mcneilneurologics/shared/pi/topamax.pdf#zoom=100. Accessed September 7, 2007.
Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with use of antiepileptic drugs. Epilepsia. 2004;45(11):1330-1337.
Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005(3):CD001133.
Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. Mov Disord. 2007;22(2):279-282.
• Back to top
